Innovative Applications and R&D Drive the Kidney Function Tests Market Growth

Global Kidney function tests market is anticipated to grow at a CAGR of 6.8% during the forecast period (2024-2031). Global Kidney function tests market is driven by factors such as the increasing prevalence of chronic kidney disease (CKD), the aging population, rising diabetes and hypertension rates, technological advancements, increasing awareness, and screening programs, rising healthcare expenditure, research and development activities, strategic collaborations and partnerships, and the regulatory environment. The increasing prevalence of CKD, the aging population, and the rise in diabetes and hypertension rates contribute to the need for early detection and monitoring of kidney dysfunction. Technological advancements have led to more accurate and efficient tests, while public health campaigns and healthcare organizations also contribute to increased testing rates. Furthermore, the market has seen significant growth primarily owing to increased focus on R&D by both public and private organizations and growing applications. For instance,

Browse the full report description of “Kidney Function Tests Market Size, Share & Trends Analysis Report by Product Type (Dipsticks, Reagents, and Disposables). by Test Type (Urine Test, and Blood Test). and by End Users (Hospitals, Diagnostic Laboratories, Research Laboratories and Institutes, and Others). Forecast Period (2024-2031).” at https://www.omrglobal.com/industry-reports/kidney-function-tests-market

In June 2023, IDEXX Laboratories launched the first veterinary diagnostic test for detecting kidney injury in cats and dogs. The IDEXX Cystatin B Test will be included in test panels assessing renal health, providing new clinical insights for an estimated two million patient visits annually. The tests will be run at IDEXX Reference Laboratories in the US and Canada. The tests offer a comprehensive view of kidney health by detecting structural injury and impaired function.

In September 2021, the National Kidney Foundation and American Society of Nephrology released a report recommending a race-free approach to diagnosing kidney disease. The report recommends the use of the new eGFR 2021 CKD EPI creatinine equation and increased use of cystatin C combined with serum creatinine. The report was drafted with input from various stakeholders to ensure accurate GFR estimation.

The market number available for – 2023-2031

• Base year- 2023

• Forecast period- 2024-2031

• Segment Covered- 

o By Product

o By Test Type

o By End User

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape-  Abbott Laboratories, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, and Siemens Healthineers co., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Kidney Function Tests Market Report Segment

By Product

• Dipsticks
• Reagents
• Disposables

By Test Type

• Urine Tests

• Urine Protein Tests
• Microalbumin Tests
• Creatinine Clearance Tests

• Blood Tests

• Serum Creatinine Tests
• Blood Urea Nitrogen Tests
• Glomerular Filtration Rate Test

By End-User

• Hospitals
• Diagnostic Laboratories
• Research Laboratories And Institutes
• Other (Clinics, Home Care Settings, and Outpatient Centers)

Global Kidney Function Tests Market Report Segment by Region

North America

• United States

• Canada 

Europe

• UK

• Germany

• Italy

• Spain

• France

• Rest of Europe 

Asia-Pacific

• China

• India

• Japan

• South Korea

• Rest of Asia-Pacific 

Rest of the World

• Latin America 

• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/kidney-function-tests-market